Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

178 results about "Tosylphenylalanyl Chloromethyl Ketone" patented technology

Novel Crystal Form of(3-Cyano-1H-Indol-7-Yl)-[4-(4-Fluorophenethyl)Piperazin-1-Yl] Methanone, Hydrochloride

The present invention relates to a hitherto unknown crystal form B of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)-piperazin-1-yl]methanone, hydrochloride, to a process for the preparation thereof, and to the use thereof for the preparation of a medicament
Owner:MERCK PATENT GMBH

Process for preparation of dronedarone by mesylation

The invention relates to a novel process for preparation of N-[2-n-butyl-3-[4-[3-(di-n-butylamino)-propoxy]-benzoyl]-benzofuran-5-yl]methanesulfonamide (I) and pharmaceutical acceptable salts thereof, where a salt of (5-amino-2-butyl-1-benzofuran-3-yl) {4-[3-(di-n-butylamino)propoxy]phenyl}methanone of formula (II)—where A is a mono- or dibasic acid forming an acid addition salt with the compound of formula (II), n is 1 if A is dibasic acid and n is 1 or 2 if A is a monobasic acid—is reacted with a mesylating reagent in a heterogen reaction, if desired, in the presence of a phase transfer catalyst. The invention also relates to the novel salts of compound of formula (II), for the preparation thereof and their use in the preparation of dronedarone.
Owner:SANOFI SA

Method for synthesizing chiral bisaryl alcohol compound

The invention discloses a method for synthesizing a chiral bisaryl alcohol compound. The method provided by the present invention specifically uses a mutant of a carbonyl reductase SSCR derived from Sporobolomyces Salmonicolor and a mutant of alcohol dehydrogenase TbSADH derived from Thermoanaerobacter brockii to catalyze asymmetric reduction of (4-chlorophenyl)pyridine-2-ketone to form (S)-(4-chlorophenyl) pyridine-2-methanol. The experiment proves that the method provided by the invention has high yield and high ee value, can reduce the addition amount of coenzyme, and does not need to add enzyme such as glucose alcohol dehydrogenase for cofactor circulation, the reaction condition is mild, and the operation is simple.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

P2X7 receptor imaging agent and preparation method thereof

The invention discloses a F-18 tagged P2X7 receptor imaging agent which is a compound 18F-{(2-chloro-3-trifluorophenyl)(1-(pyrimidin-2-yl)-6,7-dihydro-1H-[1,2,3]triazolo[4,5-c]pyridin-5(4H)-yl)methanone shown as formula I. The P2X7 receptor imaging agent is suitable for identifying and diagnosing pulmonary inflammation and tumors.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Chiral catalytic synthesis method of thiamphenicol

The invention relates to a chiral catalytic synthesis method of thiamphenicol which is a chloramphenicol broad-spectrum antibiotic. Thioanisole serves as an initating raw material, acylation and bromo are achieved, nitrogen iridine containing substituent groups is synthetized, and a qualified product which meets the requirement of drug administration is synthetized through chiral catalytic reduction, oxidizing reaction, acidification loop opening, deprotection and acylation reaction. The chiral catalytic reduction includes that under the action of a catalyst trans-RuC12[(R)-xylbinap][(S)-DPEN], [1-substituent group nitrogen iridine-2-group] [4-(methylthio group) phenyl group] ketone is subjected to hydrogenation reduction to obtain [1-substituent group nitrogen iridine-2-group] [4-(methylthio group) phenyl group] ketone with a high ee value and a high de value. D-methylsulfonylphenyl serine ethyl ester used in industrial production serves as a raw material to synthetize the thiamphenicol, the D-methylsulfonylphenyl serine ethyl ester is obtained through chemical chiral resolution by using a racemic compound, and the other half of the raw material is wasted. According to the unsymmetrical chiral catalytic dynamic reduction method, waste of the other half of the raw material is avoided, the utilization rate of a material is improved, and the production cost is reduced.
Owner:MASTEAM BIO TECH

High flow flat imitating steam mold UV curing coating and production method, construction method

The invention relates to a high-leveling vapor die imitating UV-curing coating, a production method and a construction method thereof. The coating comprises black primer or silver primer, a primer diluent and UV radiation curing varnish, wherein the primer diluent comprises 8 to 15 portions of ethylene glycol monobutyl ether, 5 to 10 portions of diacetone alcohol, 5 to 15 portions of ethylene glycol monoethyl ether, 5 to 15 portions of methylisobutylketone, 25 to 35 portions of ethyl acetate, 10 to 15 portions of isopropyl alcohol and 10 to 15 portions of isobutyl alcohol; and the UV radiation curing varnish comprises 10 to 15 portions of tripropylene glycol diacrylate, 10 to 15 portions of trimethylol-propane trimethacrylate, 20 to 30 portions of amino acrylate resin, 7 to 15 portions of Epocryl, 3 to 6 portions of 1-hydroxyl-cyclohexyl-phenyl ketone, 0.5 to 1 portion of 2, 4, 6(trimethylbenzene formacyl) diphenyl phosphine oxide, 15 to 25 portions of ethyl methyl ketone, 0.5 to 1.5 portions of polyacrylate leveling agent and 0.5 to 1.5 portions of polyether siloxane copolymer. The invention also provides a manufacturing method and a use method for the product. The high-leveling vapor die imitating UV-curing coating, is widely applied to treatment of plastic shells such as TV sets, so that the surface of a treated plastic substrate can achieve the effect of high-leveling vapor die imitating.
Owner:深圳市嘉卓成科技发展有限公司

Method for catalyzing cellulose hydrolysis by sulfonic acid functionalized ionic liquid composite system

The invention discloses a method for catalyzing cellulose hydrolysis by a sulfonic acid functionalized ionic liquid composite system. The method comprises: taking methyl isobutyl ketone-water as the solvent, adding a transition metal salt water solution and a sulfonic acid functionalized ionic liquid into cellulose to carry out reaction under a temperature of 120DEGC-180DEG C and a pressure of 2atm-3atm for 3-8h; wherein, the transition metal salt is a manganese salt, an iron salt, a ferrous salt, a cobalt salt or a zinc salt; the sulfonic acid functionalized ionic liquid is 1-(4-sulfobutyl)-3-methylimidazolium hydrogen sulfate, and the structural formula is shown as the specification. The sulfonic acid functionalized ionic liquid provided by the invention shows good catalytic activity in catalyzing cellulose hydrolysis, and when a catalytic amount of the transition metal salt (Mn<2+>, Fe<3+>, Fe<2+>, CO<2+>, Zn<2+>) is added into the system, the product selectivity and the cellulose hydrolysis efficiency are improved.
Owner:LANZHOU INST OF CHEM PHYSICS CHINESE ACAD OF SCI +1

Preparing method for osteoporosis preventing medicine

The invention relates to a preparing method for osteoporosis preventing medicine. Particularly, the invention relates to a preparing method for [6-hydroxy-2-(4-hydroxyphenyl) benzo-[b] thiophene-3-base] [4-[2-(1-piperidyl) ethyoxyl] phenyl] ketone hydrochloride. According to the preparing method, 2-halogenate-6-metoxybenzene thiophthene (II) as a beginning raw material, and a target product (I) can be prepared through coupling, fridel-crafts reaction, deprotection and salifying. The method has the advantages of being shorter in synthetic route, simple to operate, moderate in condition, high in efficiency and suitable for industrial production. (see the description).
Owner:SHANGHAI TIANCI BIOLOGICAL VALLEY BIOLOGICAL ENG

Method for increasing ketone-alcohol ratio in hydrogenation reaction of anti-aging agent 4020 by modification-catalysis

The invention belongs to the technical field of organic synthesis and specifically relates to a method for increasing the ketone-alcohol ratio in hydrogenation reaction of an anti-aging agent 4020 by modification-catalysis. The method is characterized by preparing raw materials, namely 4-aminodiphenylamine, methyl isobutyl ketone (MIBK) and an ionic liquid into a raw material solution, loading a copper-based catalyst into a fixed bed reactor, and putting the raw material solution into the fixed bed reactor in a continuous feeding and discharging way for preparing the anti-aging agent 4020 by catalytic hydrogenation, wherein the ketone-alcohol ratio after the hydrogenation reaction is significantly increased. The method provided by the invention is simple, convenient to operate, high in yield and good in selectivity, the MIBK becomes methyl isobutyl carbinol (MIBC) by hydrogenation, and side effects are obviously inhibited, so that the method is conductive to increasing the ketone-alcohol ratio after catalytic hydrogenation in industrial production, reducing the consumption of the MIBK and greatly reducing the production cost.
Owner:CHINA PETROLEUM & CHEM CORP +1

Staining-resisting UV (Ultraviolet) coating as well as preparation method and application technology thereof

The invention belongs to the field of coating and relates to staining-resisting UV (Ultraviolet) coating as well as a preparation method and an application technology thereof. The staining-resisting UV coating is prepared from the following components in percentage by weight: 50 to 60 weight percent of fluorosilicon modified acrylate, 10 to 15 weight percent of dipentaerythritol hexaacrylate, 10 to 15 weight percent of propoxylated pentaerythitol tetraacrylate, 3 to 5 weight percent of 1-hydroxyl-cyclohexyl-phenyl ketone, 2 to 5 weight percent of (2,4,6-trimethylbenzoyl)diphenyl phosphine oxide, 0.2 to 1 weight percent of a de-foaming agent, 0.2 to 1 weight percent of a flatting agent and 5 to 15 weight percent of a diluting agent, wherein the diluting agent is a mixture of absolute ethylalcohol and dicarboxylate. Compared with the prior art, the staining-resisting UV coating provided by the invention has high reaction activity and a rapid curing speed and the coating has a low shrinkage rate; and a formed coating film has a strong attachment force and excellent flexibility and is continuous and stable.
Owner:FOSHAN LANGTAI BUILDING MATERIAL CO LTD

Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use

Solid amorphous and crystalline forms of (3′-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone are disclosed, in addition to methods of their use in the treatment of various diseases and disorders.
Owner:LEXICON PHARM INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products